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Th e quality of life of patients with 
lupus erythematosus infl uences cardiovascular 
capacity in 6-minute walk test 
Sandor Balsamo1, Dahan da Cunha Nascimento2, Ramires Alsamir Tibana3, Frederico Santos de Santana4, 
Licia Maria Henrique da Mota5, Leopoldo Luiz dos Santos-Neto6
ABSTRACT
Objective: To assess the association between quality of life and distance walked in the 6-minute walk test (6MWT) 
in Brazilian premenopausal patients with systemic lupus erythematosus (SLE) and compare their results with those 
of healthy controls. Methods: Twenty-¿ ve premenopausal (18–45 years) patients diagnosed with low-activity SLE 
(mean SLEDAI: 1.52 ± 1.61) and 25 controls were matched for age, physical characteristics, and physical activity 
level (International Physical Activity Questionnaire/s-IPAQ). Both groups should not be involved in regular physical 
activity for at least six months before the study. The 6MWT distance (American Thoracic Society protocol), posttest 
heart rate (HRpost), posttest oxygen saturation (SpO2post) and the Borg scale of subjective perception of effort (SPE/
CR10) were evaluated. The quality of life was assessed by use of the Short Form Health Survey 36 (SF-36). Results: 
Patients with SLE had a signi¿ cantly poorer quality of life, a shorter 6MWT distance (598 ± 45 m versus 642 ± 14 m, P 
< 0.001), and greater values of SPE/CR10 (6.28 ± 2.0 versus 5.12 ± 1.60, P  0.05) and HRpost (134 ± 15 bpm versus 
123 ± 23 bpm, P  0.05) when compared with controls. The linear regression model suggested that quality of life was 
a signi¿ cant predictor of 70% of the 6MWT distance. Conclusion: When compared with controls, patients with SLE 
walked a shorter distance in the 6MWT, which was associated with poorer quality of life.
Keywords: systemic lupus erythematosus, physical ¿ tness, quality of life, 6-minute walk test.
© 2013 Elsevier Editora Ltda. All rights reserved.
INTRODUCTION 
Patients with systemic lupus erythematosus (SLE) are at in-
creased risk for acute myocardial infarction, up to seven times 
that of the healthy population.1,2 In addition to a greater cardio-
vascular risk, women with SLE have lower cardiorespiratory 
capacity as compared with that of healthy women.3
Another aspect that might aggravate their cardiovascular risk 
is the high percentage of physically inactive patients,4 directly 
affecting their quality of life.5 Previous studies have reported an 
association between lower oxygen consumption (direct measure 
of peak oxygen) and worse quality of life in patients with SLE.5 
However, the conventional test is time-consuming, requires 
specialized equipment, which has a high cost and is not practical 
for hospitals, clinics and physical activity centers.
A practical strategy to aid in the assessment of the clinical 
status for the patient’s cardiovascular prognosis is the 6-minute 
walk test (6MWT). The 6MWT requires a walkway with at 
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least 30 meters and an oximeter.6 However, so far, no study 
has assessed the 6MWT in patients with SLE and compared 
its results with those of healthy women. In addition, it is not 
clear whether there is an association between the distance 
walked in the 6MWT and the quality of life of patients with 
SLE. The results of that investigation might aid health pro-
fessionals to control the quality of life and to assess clinical 
aspects and the cardiovascular capacity of patients with SLE, 
in addition to providing comparative parameters with the 
healthy population.
The present study aimed at: 1) assessing the association 
between the distance walked in the 6MWT and the qual-
ity of life of premenopausal patients with low activity SLE; 
2) comparing the results with those of healthy women  matched 
for gender, age, physical activity level and physical characteris-
tics. The hypothesis of the present study was that patients with 
SLE would walk a shorter distance in the 6MWT, which would 
be associated with an impaired quality of life.
MATERIAL AND METHODS 
Study participants and design
This study was conducted from January, 20th 2009 to January, 
31st 2011, and was approved by the Committee of Ethics 
and Research of the Medical School of the Universidade 
de Brasília (FM-UnB) (protocol CEP-FM 074//2005), in 
accordance with the Helsinki declaration.7 It is part of the 
LUPUSFIT study, a research project aimed at assessing 
the various aspects related to physical ¿ tness and health of 
Brazilian females with SLE – linked to the laboratory of phys-
ical ¿ tness and rheumatology (LAR) of Hospital Universitário 
de Brasília (HUB). All participants provided written informed 
consent to undergo all tests. Twenty-¿ ve premenopausal pa-
tients with SLE met the American College of Rheumatology 
(ACR) criteria8,9 and were on regular follow-up at the service 
of rheumatology of the HUB. Twenty-¿ ve healthy women 
(controls) were matched for gender, age, physical activity 
level and physical characteristics. 
This study included female patients with SLE according 
to the ACR criteria,8,9 who were on regular follow-up at the 
service of rheumatology of the HUB and had low disease activ-
ity (SLEDAI  5). All study participants should be between 18 
and 45 years of age, and not exercising for at least 6 months 
before the beginning of this study (on average, less than once 
a week). To identify the type of exercises, their regularity, 
frequency, intensity and duration, a questionnaire10 with the 
following three questions was used: 1) What type of physical 
exercise do you practice regularly during the week?; 2) What is 
the week frequency of that exercise?; and 3) What is the mean 
duration, in minutes, of a single session of physical exercise? 
Patients with SLE and the following characteristics were 
excluded from the study: SLEDAI > 5; serum creatinine 
 4,770 mg/dL or 265 mmol/L, hematocrit  30%, nephritis and/
or leukopenia; beta-blocker use, previous history of myocardial 
infarction, cardiomyopathy and/or systemic arterial hyperten-
sion; diabetes mellitus; neurological disorders; hypothyroidism; 
¿ bromyalgia; locomotor disorders (fractures and prostheses) 
and/or osteoporosis; rheumatoid arthritis (RA); Sjögren’s syn-
drome; cancer; age < 18 years; age > 45 years; geographical 
dif¿ culties (living far from the city of Brasília); body mass index 
(BMI) < 18 kg/m2; body surface > 30 kg/m2 (obesity); tobacco 
use; pregnancy; and regular exercise practice (on average, at 
least twice a week).
METHODS
The study participants visited the laboratory of human perfor-
mance of the Centro Universitário Euroamericano (UNIEURO) 
twice , at a minimum interval of 48 hours and maximum interval 
of 72 hours, always at the same time (between 2PM and 4PM). 
In the 24 hours preceding their visits to that laboratory, the 
participants had to avoid any intense activity and the consump-
tion of caffeine and alcoholic beverages. Their last meal should 
precede the test by at least 2 hours and the participants should 
not be menstruating on the day of the test. On their ¿ rst visit, 
the quality of life questionnaire was applied, anthropometric 
measures were taken, and the 6MWT performed. On their second 
visit, the 6MWT was repeated.
Physical activity level 
Aiming at assessing the patient’s daily physical activity level, 
the Physical Activity Questionnaire-Short Form (IPAQ-S),11,12 
validated to the Brazilian population,12 was used. That question-
naire was applied individually by the major investigator and 
comprised questions about the frequency (days per week) and 
duration (minutes per day) of activities involving moderate and 
vigorous physical exertion in four domains: work commuting; 
household chores; leisure; and the number of hours that patients 
with SLE and controls remained seated during the week and 
during the weekend. According to their physical activity levels, 
patients were classi¿ ed as follows: active; irregularly active; 
and sedentary.
Quality of life 
Quality of life was assessed by use of the Short Form Health 
Survey 36 (SF-36),13 containing 36 items grouped into eight 
RBR 53(1).indb   Miolo76 20/03/2013   16:25:56
The quality of life of patients with lupus erythematosus inﬂ uences cardiovascular capacity in 6-minute walk test 
77Rev Bras Reumatol 2013;53(1):75–87
domains: physical functioning; role limitation due to physical 
health; bodily pain; general health perception; vitality; social 
functioning; role limitation due to emotional problems; and 
mental health. Each domain’s score ranges from 0 to 100, 
the highest score indicating better health conditions related 
to quality of life. 
Anthropometric measures
One single observer assessed the following measures: 
height; body mass, BMI (kg/m2); and body composition [fat 
percentage; three skinfold measurements: triceps, suprailiac 
and thigh; Lange Skinfold Calipers (Cambridge Scienti¿ c 
Industries, Cambridge, MD)].14 
The 6-minute walk test 
The 6MWT was performed according to the American Thoracic 
Society protocol.6 Functional capacity was determined by the 
distance walked in a covered 30-meter walkway. After the 
6MWT, the following were used: an oximeter (NONIN, model 
9500, USA), to assess posttest heart rate (HRpost) and posttest 
oxygen saturation (SpO2post); and the Borg scale of subjective 
perception of effort (SPE), ranging from 0 to 10 (SPE/CR-10; 
0 = rest, 10 = maximum effort possible).
15
Statistical analysis
A minimum sample of 25 volunteers for each group, with test 
power of 90%, was estimated to indicate a difference between 
the groups, the size of the effect being 0.97. The sample size 
was calculated based on a pilot study.3,16 Normality of the data 
was assessed by using the Kolmogorov-Smirnov test. The 
variables with a normal distribution were shown as mean ± 
standard deviation; those without a normal distribution were 
shown as median with an interquartile interval. 
To compare the means of the measures of the distance 
walked during the 6MWT, HRpost, SpO2post and SPE/
CR10 between both groups, the Student t test was used for 
independent samples in the variables with a Gaussian dis-
tribution, in which the difference between the means with a 
95% con¿ dence interval (95% CI) was obtained. When no 
normality was observed in the groups, the nonparametric 
Mann-Whitney test was used. 
The Pearson’s chi-square test was used to assess the as-
sociation between the group and the physical activity level. 
In accordance with Tench et al.,5 the forward linear regres-
sion model was used to assess the relationship between the 
dependent variable ‘distance walked’ in the 6MWT and the 
independent variable ‘quality of life’ (SF-36), and between the 
independent variable 6MWT in patients with SLE. The SAS 
for Windows 9.2 (SAS Institute Inc., Cary, NC, USA) was 
used in the analyses. A 5% signi¿ cance level was adopted.
RESULTS
Study participants 
From January 20th 2009 to January 31st 2011, 25 pa-
tients with low activity SLE [mean SLEDAI: 1.52 ± 1.61; 
variation: 0–5; 9 patients (36%) had a score of 0] were 
assessed. Mean disease duration was 5.3 ± 4.6 years 
(range: 1–20 years). The patients were on regular treat-
ment as follows: prednisone = 21/25 (84%), mean dose 
= 6.07 ± 2.18 mg/day, range = 5–20 mg/day; azathio-
prine = 8/25 (32%), mean dose = 87.50 ± 46.88 mg/day, 
range = 50–200 mg/day; chloroquine diphosphate = 17/25 
(68%), mean dose = 205.88 ± 66.44 mg/day; and hydroxy-
chloroquine = 2/25 (8%), mean dose = 400 ± 0.0 mg/day. 
Twenty-¿ ve healthy women matched for age and physical 
characteristics were selected (Table 1). 
International Physical Activity Questionnaire
Compared with controls, the patients with SLE did not statisti-
cally differ regarding their physical activity level (P = 0.127), 
which was as follows: 17/25 (68%) were considered active; 
3/25 (12%) were considered irregularly active; and 5/25 
(20%) were considered sedentary. The physical activity level 
of the control group was as follows: 23/25 (92%) patients 
were considered active; 1/25 (4%) were considered irregularly 
active; and 1/25 (4%) were considered sedentary. The patients 
with SLE did not statistically differ regarding the time they 
remained seated during the week (SLE = 251.00 ± 148.16 
hours versus controls = 287.00 ± 215.76 hours; P = 0.80), and 
during the weekend (SLE = 266.00 ± 146.46 hours versus 
controls: 253.80 ± 200.08 hours; P = 0.40).
Quality of life 
Table 2 shows data regarding the patients’ quality of life. 
The SF-36 showed that patients with SLE had a worse qual-
ity of life in the following domains: general health percep-
tion; physical functioning; role limitation due to emotional 
problems; social functioning; role limitation due to physical 
health; and mental health (all, P < 0.05). Neither vitality nor 
bodily pain differed (both, P > 0.05). 
The 6-minute walk test 
Table 3 shows data regarding the 6MWT. Compared with 
controls, the patients with SLE walked a shorter distance 
(P < 0.001) and had higher SPE/CR10 (P < 0.05) and HRpost 
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Table 1
Physical characteristics of patients with systemic lupus erythematosus and healthy women (control group)*
Variable SLE (n = 25) Control (n = 25) Difference between means (95% CI)# P
Age, years, median (IQR)+ 29.9 (6.8) 29.2 (8.0) — 0.7671
Body mass, kg 57.7 ± 6.7 58.3 ± 8.2 0.69 (−3.5; 4.9) 0.7462
Height, cm 158.0 ± 0.1 158.0 ± 0.1 −0.01 (−0.5; 0.0) 0.6573
Lean body mass, kg 38.0 ± 4.8 38.5 ± 3.8 0.49 (−2.0; 2.9) 0.6966
BMI, kg/height2 23.0 ± 2.9 23.5 ± 3.3 0.47 (−1.3; 2.2) 0.5998
SLE: systemic lupus erythematosus; 95%CI: 95% conﬁ dence interval; IQR: interquartile range; BMI: body mass index.
*Values expressed as mean ± standard deviation, unless otherwise speciﬁ ed.
#Calculated only when the Student t test was used.
+These variables do not have normal distribution, being, thus, expressed as median.
Table 2
Results regarding quality of life (SF-36) of patients with systemic lupus erythematosus and in healthy women (control group)*
Variable SLE (n = 25) Control (n = 25) Difference between means (95%CI)# P
Quality of life, SF-36
Physical functioning, median (IQR)+ 61.6 (24.4) 81.2 (14.5) — 0.0029
Role limitations due to physical health, median (IQR)+ 53.0 (41.0) 78.0 (25.3) — 0.0375
Bodily pain, median (IQR)+ 64.4 (25.7) 72.9 (22.0) — 0.2752
General health perceptions 51.1 ± 17.8 67.5 ±16.3 16.3 (6.6; 26.1) 0.0014
Vitality, median (IQR)+ 54.8 (11.5) 55.2 (10.3) — 0.9686
Social functioning, median (IQR)+ 68.4 (24.0) 83.8 (18.3) — 0.0266
Role limitations due to emotional problems 41.2 (39.9) 73.1 (36.0) — 0.0073
Mental health, median (IQR)+ 50.0 ± 13.2 58.5 ± 10.5 8.5 (1.74; 15.4) 0.0150
SLE: systemic lupus erythematosus; 95%CI: 95% conﬁ dence interval; IQR: interquartile range; SF-36: Short Form Health Survey 36.
* Values expressed as mean ± standard deviation, unless otherwise speciﬁ ed.
#Calculated only when the Student t test was used.
+These variables do not have normal distribution, being, thus, expressed as median.
Table 3
Results of the 6-minute walk test of patients with systemic lupus erythematosus and healthy women (control group)*
Variable SLE (n = 25) Control (n = 25) Difference between means (95% CI)# P
6MWT 598.1 ± 45.5 642.4 ± 39.1 44.3 (20.2; 68.5) 0.0006
SPE/CR10, median (IQR)+ 6.2 ± 2.0 5.1 ± 1.6 0.0358
SpO2PRE, (%), median (IQR)
+ 98.1 (0.6) 97.6 (1.3) 0.3588
SPO2POST, (%), median (IQR)
+ 98.1 ± 1.3 98.0 ± 1.0 0.5864
HRPRE, BPM 80.5 ± 10.3 81.7 ± 14.9 1.2 (−6.1; 8.5) 0.7432
HRPOST, BPM 134.3 ± 15.5 123.0 ± 23.6 −11.2 (−22.6; 0.0) 0.0544
SLE: systemic lupus erythematosus; 95%CI: 95% conﬁ dence interval; IQR: interquartile range; 6MWT: 6-minute walk test; SPE/CR10: subjective perception of effort in each series, scale from 0 to 10; SpO
2PRE
: 
peripheral oxygen saturation at rest prior to the 6MWT; SpO
2POST
: peripheral oxygen saturation after the 6MWT; HRPRE: heart rate at rest prior to the 6MWT; FCPOST: heart rate after the 6MWT; BPM: beats 
per minute.
* Values expressed as mean ± standard deviation, unless otherwise speciﬁ ed.
#Calculated only when the Student t test was used.
+These variables do not have normal distribution, being, thus, expressed as median.
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(P = 0.05) than controls. Patients with SLE did not differ re-
garding SpO2post (P = 0.35). 
Linear regression model
The ¿ nal linear regression model for 6MWT, which included 
the SF-36 variables (mental health, physical functioning, social 
functioning and role limitation due to emotional problems), 
accounted for 70% of the distance walked in the 6MWT 
(P  0.01) (Table 4).
DISCUSSION
The present study aimed at: 1) assessing the association be-
tween distances walked in the 6MWT and the quality of life of 
premenopausal patients with low activity SLE; 2) comparing 
those results with those of healthy women  matched for gender, 
age, physical activity level and physical characteristics. In ad-
dition, HRpost, SpO2post, and SPE/CR10 were assessed. The 
results of the tests con¿ rm our hypothesis that the patients with 
SLE walked a shorter distance in the 6MWT as compared with 
controls. The linear regression model showed that the qual-
ity of life was a signi¿ cant predictor of 70% of the distance 
walked in the 6MWT. 
We know no previous evidence of the association between 
the distance walked in the 6MWT and the quality of life of 
patients with SLE. This study provides evidence that the 
quality of life of patients with SLE, per se, is associated with 
a reduction in the cardiovascular capacity assessed by use of 
the 6MWT. In addition, in a practical and simple way, the 
6MWT con¿ rmed the results of the study by Tench et al.,5 in 
which high-cost equipment has been used to assess cardio-
vascular capacity, and which has shown an association of the 
cardiovascular capacity, assessed by use of the treadmill test 
and bicycle ergometer, with quality of life.5
However, Bostrom et al.17 have reported that 26% of 
the patients undergoing treadmill tests do not achieve the 
minimum velocity of 5 km/h,5 possibly due to biomechanical 
issues.17 Similarly, when the tests are performed on a bicycle 
ergometer, the major limitation is that 50% of the patients 
have peripheral fatigue prior to central fatigue.18 In addition, 
the conventional test is time-consuming, requires specialized 
equipment, which has a high cost and is not practical for hos-
pitals, clinics and physical activity centers. Thus, the 6MWT 
might be a more practical tool to aid with the cardiovascular 
clinical prognosis of patients with SLE.
The only study performed so far with the 6MWT was that 
by Hougthon et al.,18 showing that young patients with SLE 
walked a shorter distance than that predicted for the same 
age group. However, this is the ¿ rst study using the 6MWT 
to compare the cardiovascular capacity of adult patients with 
SLE and controls. The results of the present study con¿ rm the 
¿ ndings of several studies in which patients with SLE have 
lower cardiovascular capacity and higher values of SPE and 
HR than those of controls.3 However, the previous studies 
have been performed with treadmills or bicycle ergometers.3 
The shorter distance walked and the worse quality of life 
of patients with SLE might relate to the time for disease diag-
nosis,19 depression, and cognitive dysfunction.20 Tench et al.5 
have reported that the lower cardiovascular capacity might be 
associated with the fatigue of patients with SLE. That symp-
tom is also associated with a reduced functional performance21 
and might relate to the cycle that reduces physical ¿ tness 
(muscle strength/cardiovascular capacity), thus reducing the 
ability to perform daily activities3 and impairing the quality 
of life of those patients. Another explanation might be the 
type I and II muscle ¿ ber atrophy,22,23 and the mitochondrial 
damage due to long-term corticosteroid therapy.24
Some limitations of this study should be considered. 
1) The generalization of our results should be limited due to 
the homogeneity of the sample studied. The patients studied 
originated from one single hospital, and their physical char-
acteristics, age, and physical activity level were similar to 
those of the control group. In addition, the sample size was 
relatively small. However, the homogeneity of both groups 
strengthens the internal validity of this study, minimizing 
potential confounding factors attributed to that aspect, such 
as perimenopause, ¿ bromyalgia, tobacco use, obesity, and 
beta-blocker and statin use. In the present study, those factors 
were similar in patients with SLE and controls. In addition, 
only patients with low activity SLE participated in this 
study. All those aspects were methodologically controlled to 
minimize interference in the distance walked in the 6MWT. 
Table 4
Linear regression model of the 6-minute walk test
Dependent 
variable
Independent 
variable PE
Standard 
error R
2 P
6MWT Functional capacity (SF-36) 2.26 0.33 0.20 < 0.0001
Social aspects 
(SF-36) −1.14 0.31 0.44 0.0014
Emotional 
aspects (SF-36) −0.68 0.18 0.60 0.0010
Mental health 
(SF-36) −1.16 0.44 0.70 0.0155
R2: coefﬁ cient of determination; PE = parameter estimate; 6MWT: 6-minute walk test; SF-36: Short 
Form Health Survey 36.
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2) The cross-sectional nature of this study establishes no 
cause-effect relationship. However, the objective of this 
study was to raise hypotheses for future studies aimed at 
assessing the clinical effects of exercise on the health and 
quality of life of patients with SLE. In addition, the 6MWT 
was used, a test that, considering the reality of the Brazilian 
Uni¿ ed Health System (SUS), might have greater practical 
applicability for cardiovascular prognosis, differently from 
conventional tests.
Concluding, the present study evidenced that factors related 
to quality of life are predictors of cardiovascular capacity. We 
investigated that association by using the 6MWT in patients 
with SLE. In addition, reduced cardiovascular capacity and 
SLE are associated with increased morbidity and mortality. 
Thus, assessing cardiovascular capacity by use of the 6MWT 
and encouraging the practice of exercises might improve the 
quality of life of patients with SLE. Those possible bene¿ ts, 
however, should be assessed in further studies.
This article is part of the PhD thesis of Sandor Balsamo held at 
the Post-Graduate Medical Sciences, Faculdade de Medicina, 
Universidade de Brasília.
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à homogeneidade da amostra estudada. As pacientes do estudo 
eram de um mesmo centro hospitalar, e eram similares ao 
grupo-controle quanto a características físicas, idade e nível 
de atividade física. Além disso, contamos com uma amostra 
relativamente pequena. Por outro lado, a homogeneidade 
entre os dois grupos reforça a validade interna do estudo, 
minimizando os potenciais fatores de confusão atribuídos 
a esses aspectos, como a perimenopausa, a ¿ bromialgia, o 
tabagismo, a obesidade, o uso de betabloqueador e a estatina. 
No presente estudo, esses fatores foram semelhantes entre 
pacientes com LES e grupo-controle. Além disso, apenas as 
pacientes com LES em baixa atividade da doença participaram 
do estudo. Todos esses aspectos foram metodologicamente 
controlados para que fossem mínimas as interferências sobre 
a distância percorrida no 6TC; 2) a natureza da seção trans-
versal do estudo não estabelece relação de causa e efeito. No 
entanto, o objetivo foi levantar hipóteses para futuros estudos 
que visem analisar os efeitos clínicos do exercício na saúde 
e na qualidade de vida de pacientes com LES. Ao mesmo 
tempo, foi utilizado o 6TC, que para a realidade do Sistema 
Único de Saúde (SUS) pode ter maior aplicabilidade prática 
para prognóstico cardiovascular – diferentemente dos testes 
convencionais.
Em conclusão, o presente estudo forneceu evidências de 
que fatores relacionados à qualidade de vida são preditores 
para capacidade cardiovascular. De forma inédita, investi-
gamos esta associação por meio do 6TC em pacientes com 
LES. Além disso, a diminuição da capacidade cardiovascular 
e o LES estão associados ao aumento da morbimortalidade. 
Portanto, avaliar a capacidade cardiovascular pelo 6TC e 
incentivar a prática de exercícios poderá implicar melhora da 
qualidade de vida de pacientes com LES. Contudo, esses pos-
síveis benefícios devem ser examinados em estudos futuros.
Este artigo é parte da tese de Doutorado de Sandor Balsamo 
realizado no programa de Pós-graduação em Ciências Médicas 
da Faculdade de Medicina da Universidade de Brasília.
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